CoChat

Aberrant Methylation of Gene Associated CpG Sites Occurs in Borderline Personality Disorder

Open access
Teschler, Stefanie, Bartkuhn, Marek, Künzel, Natascha, Schmidt, Christian, Kiehl, Steffen, Dammann, Gerhard, Dammann, Reinhard · 2013 · PLoS ONE

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Abstract

Borderline personality disorder (BPD) is a complex psychiatric disease with an increased impact in the last years. While the diagnosis and therapy are well established, little is known on the pathogenesis of borderline personality disorder. Previously, a significant increase in DNA methylation of relevant neuropsychiatric genes in BPD patients has been reported. In our study we performed genome wide methylation analysis and revealed specific CpG sites that exhibited increased methylation in 24 female BPD patients compared to 11 female healthy controls. Bead chip technology and quantitative bisulfite pyrosequencing showed a significantly increased methylation at CpG sites of APBA2 (1.1 fold) and APBA3 (1.1 fold), KCNQ1 (1.5 fold), MCF2 (1.1 fold) and NINJ2 (1.2 fold) in BPD patients. For the CpG sites of GATA4 and HLCS an increase in DNA methylation was observed, but was only significant in the bead chip assay. Moreover genome wide methylation levels of blood samples of BPD patients and control samples are similar. In summary, our results show a significant 1.26 fold average increase in methylation at the analyzed gene associated CpG sites in the blood of BPD patients compared to controls samples (p<0.001). This data may provide new insights into epigenetic mechanisms underlying the pathogenesis of BPD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0084180

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Methylation rate at 27,578 individual CpG target sites from 24 female BPD patients and 11 female control samples. Scatter plot of pairwise comparison between female BPD patients and controls (A) and volcano plot for visualization of differentially methylated probes between both groups (B). Methylation levels of 27,578 CpGs sites were revealed by HumanMethylation27 bead chip technology and the average beta-value (beta) and the absolute DiffScore for patients and control groups was determined. Beta is the ratio of the methylated signal to the sum of unmethylated and methylated signal. The DiffScore is a transformation of the p-value that provides directionality to the p-value based on the difference between the average signal in the reference group vs. the comparison group. The formula is: DiffScore = 10*sgn(µcond-µref)*log10p; For a p-value of 0.05 the DiffScore is ~13. 259 CpGs exhibited a significantly higher DiffScore (≥13). Analyzed CpGs of APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 are indicated.
Figure 1 Methylation rate at 27,578 individual CpG target sites from 24 female BPD patients and 11 female control samples. Scatter plot of pairwise comparison between female BPD patients and controls (A) and volcano plot for visualization of differentially methylated probes between both groups (B). Methylation levels of 27,578 CpGs sites were revealed by HumanMethylation27 bead chip technology and the average beta-value (beta) and the absolute DiffScore for patients and control groups was determined. Beta is the ratio of the methylated signal to the sum of unmethylated and methylated signal. The DiffScore is a transformation of the p-value that provides directionality to the p-value based on the difference between the average signal in the reference group vs. the comparison group. The formula is: DiffScore = 10*sgn(µcond-µref)*log10p; For a p-value of 0.05 the DiffScore is ~13. 259 CpGs exhibited a significantly higher DiffScore (≥13). Analyzed CpGs of APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 are indicated.CC BY · PubMed Central
Figure 2 Map of the investigated genomic regions. Positions of the analyzed CpG sites of APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 are shown (http://genome.ucsc.edu). CpGs are indicated with vertical lines and the analyzed CpGs are numbered. The bold and underlined CpG sites were identified as differentially methylated in the 27K bead chip assay. Primers and transcriptions start sites are marked with arrows. Graphics were generated with the python.vs.cobra program (https://launchpad.net/python.vs.cobra).
Figure 2 Map of the investigated genomic regions. Positions of the analyzed CpG sites of APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 are shown (http://genome.ucsc.edu). CpGs are indicated with vertical lines and the analyzed CpGs are numbered. The bold and underlined CpG sites were identified as differentially methylated in the 27K bead chip assay. Primers and transcriptions start sites are marked with arrows. Graphics were generated with the python.vs.cobra program (https://launchpad.net/python.vs.cobra).CC BY · PubMed Central
Figure 3 Methylation analysis of APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 by bisulfite pyrosequencing. PCR products obtained from three independent bisulfite treated DNA of female BPD patients (n=9) and controls (n=8) were analyzed. Average methylation levels ± SD of individual CpG sites from three independent pyrosequencing reactions are indicated and summarized for all CpGs. Significant p-values are indicated (two-tailed t-test).
Figure 3 Methylation analysis of APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 by bisulfite pyrosequencing. PCR products obtained from three independent bisulfite treated DNA of female BPD patients (n=9) and controls (n=8) were analyzed. Average methylation levels ± SD of individual CpG sites from three independent pyrosequencing reactions are indicated and summarized for all CpGs. Significant p-values are indicated (two-tailed t-test).CC BY · PubMed Central
Figure 4 Methylation changes between female BPD patients and controls. The quotient between mean methylation levels at individual CpG sites and combined sites for APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 in BPD patients and controls were calculated and plotted. P-values are indicated (two-tailed t-test).
Figure 4 Methylation changes between female BPD patients and controls. The quotient between mean methylation levels at individual CpG sites and combined sites for APBA2, APBA3, GATA4, HLCS, KCNQ1, MCF2, NINJ2 and TAAR5 in BPD patients and controls were calculated and plotted. P-values are indicated (two-tailed t-test).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. G Dammann, 2003, Differential diagnosis of psychotic symptoms in adolescents and young adults with borderline personality disorder, Psychiatr Prax, 30, 304

Cited by

See all 36

Metadata

Authors
Teschler, S., Bartkuhn, M., Künzel, N., Schmidt, C., Kiehl, S., Dammann, G., & Dammann, R.
Affiliations
  • Justus-Liebig-Universität Gießen (DE)
  • University of Basel (CH)
Corresponding author
Dammann, Reinhard
Venue
PLoS ONE
Published
2013-12-19
Volume
8
Issue
12
Pages
e84180
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1980253907
Cited by
36
References
73
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 8 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 2
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Deutsche Forschungsgemeinschaft (TRR81)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
  • Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
Keywords
borderline personality disorder, DNA methylation, CpG sites, epigenetics, KCNQ1, NINJ2, GATA4, blood DNA, female patients, pathogenesis
MeSH terms
Adult, Borderline Personality Disorder, Female, Humans, Case-Control Studies, CpG Islands, DNA Methylation, Oligonucleotide Array Sequence Analysis, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.